Quote:

---

With that number of symptoms spread unevenly over the population of the suffering, the trial would have to be massive to fully test all of the symptoms.

---

A trial can be focused via exclusion/inclusion on key symptoms that are having the most detrimental effect. In NASH and cancer Cytodyn will be competing against many larger BPs for a fewer number of patients. We've seen how that can drag out trial length with Covid.

Quote:

---

But if you have runny nose, fatigue, or cough, how much do you want to spend on a drug to help you? I.e., go for a market where it's okay to charge a substantial amount.

---

That is a downplaying of what many patients are experiencing, just as was done with ME/CFS.